BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29665321)

  • 1. A novel ANO5 splicing variant in a LGMD2L patient leads to production of a truncated aggregation-prone Ano5 peptide.
    Xu J; Xu L; Lau YS; Gao Y; Moore SA; Han R
    J Pathol Clin Res; 2018 Apr; 4(2):135-145. PubMed ID: 29665321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic anoctamin-5 protein defect in patients with ANO5-mutated muscular dystrophy.
    Vihola A; Luque H; Savarese M; Penttilä S; Lindfors M; Leturcq F; Eymard B; Tasca G; Brais B; Conte T; Charton K; Richard I; Udd B
    Neuropathol Appl Neurobiol; 2018 Aug; 44(5):441-448. PubMed ID: 28489263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anoctamin 5 Knockout Mouse Model Recapitulates LGMD2L Muscle Pathology and Offers Insight Into in vivo Functional Deficits.
    Thiruvengadam G; Sreetama SC; Charton K; Hogarth M; Novak JS; Suel-Petat L; Chandra G; Allard B; Richard I; Jaiswal JK
    J Neuromuscul Dis; 2021; 8(s2):S243-S255. PubMed ID: 34633328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recessive mutations in the putative calcium-activated chloride channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies.
    Bolduc V; Marlow G; Boycott KM; Saleki K; Inoue H; Kroon J; Itakura M; Robitaille Y; Parent L; Baas F; Mizuta K; Kamata N; Richard I; Linssen WH; Mahjneh I; de Visser M; Bashir R; Brais B
    Am J Hum Genet; 2010 Feb; 86(2):213-21. PubMed ID: 20096397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel ANO5 mutations causing hyper-CK-emia, limb girdle muscular weakness and Miyoshi type of muscular dystrophy.
    Schessl J; Kress W; Schoser B
    Muscle Nerve; 2012 May; 45(5):740-2. PubMed ID: 22499103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of muscular dystrophy in a CRISPR-engineered mutant rabbit model with frame-disrupting ANO5 mutations.
    Sui T; Xu L; Lau YS; Liu D; Liu T; Gao Y; Lai L; Han R; Li Z
    Cell Death Dis; 2018 May; 9(6):609. PubMed ID: 29789544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anoctamin 5 (ANO5) Muscle Disorders: A Narrative Review.
    Soontrapa P; Liewluck T
    Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophy.
    Hicks D; Sarkozy A; Muelas N; Köehler K; Huebner A; Hudson G; Chinnery PF; Barresi R; Eagle M; Polvikoski T; Bailey G; Miller J; Radunovic A; Hughes PJ; Roberts R; Krause S; Walter MC; Laval SH; Straub V; Lochmüller H; Bushby K
    Brain; 2011 Jan; 134(Pt 1):171-182. PubMed ID: 21186264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic Spectrum of Myopathies with Recessive Anoctamin-5 Mutations.
    Vázquez J; Lefeuvre C; Escobar RE; Luna Angulo AB; Miranda Duarte A; Delia Hernandez A; Brisset M; Carlier RY; Leturcq F; Durand-Canard MC; Nicolas G; Laforet P; Malfatti E
    J Neuromuscul Dis; 2020; 7(4):443-451. PubMed ID: 32925086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ANO5 mutations in the Polish limb girdle muscular dystrophy patients: Effects on the protein structure.
    Jarmula A; Łusakowska A; Fichna JP; Topolewska M; Macias A; Johnson K; Töpf A; Straub V; Rosiak E; Szczepaniak K; Dunin-Horkawicz S; Maruszak A; Kaminska AM; Redowicz MJ
    Sci Rep; 2019 Aug; 9(1):11533. PubMed ID: 31395899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anoctamin-5 Muscular Dystrophy: Report of Two Cases with Different Phenotypes and Genotypes from the Indian Subcontinent.
    Mahajan S; Dhall A; Jassal B; Saluja A; Faruq M; Suri V; Rajan R; Vishnu VY; Sharma MC
    Neurol India; 2022; 70(5):2169-2173. PubMed ID: 36352632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anoctamin 5 (ANO5) muscular dystrophy-three different phenotypes and a new histological pattern.
    Seguí F; Gonzalez-Quereda L; Sanchez A; Matas-García A; Garrabou G; Rodriguez MJ; Gallano P; Grau JM; Milisenda JC
    Neurol Sci; 2020 Oct; 41(10):2967-2971. PubMed ID: 32399949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limb girdle muscular dystrophy type 2L presenting as necrotizing myopathy.
    Schneider I; Stoltenburg G; Deschauer M; Winterholler M; Hanisch F
    Acta Myol; 2014 May; 33(1):19-21. PubMed ID: 24843231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Japanese male with a novel ANO5 mutation with minimal muscle weakness and muscle pain till his late fifties.
    Kadoya M; Ogata K; Suzuki M; Honma Y; Momma K; Yatabe K; Tamura T; Kaida K; Miyata N; Nishino I; Nonaka I; Kawai M
    Neuromuscul Disord; 2017 May; 27(5):477-480. PubMed ID: 28214267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and characterisation of anoctamin 5 mutations in a cohort of Italian limb-girdle muscular dystrophy patients.
    Magri F; Del Bo R; D'Angelo MG; Sciacco M; Gandossini S; Govoni A; Napoli L; Ciscato P; Fortunato F; Brighina E; Bonato S; Bordoni A; Lucchini V; Corti S; Moggio M; Bresolin N; Comi GP
    Neuromuscul Disord; 2012 Nov; 22(11):934-43. PubMed ID: 22742934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective membrane fusion and repair in Anoctamin5-deficient muscular dystrophy.
    Griffin DA; Johnson RW; Whitlock JM; Pozsgai ER; Heller KN; Grose WE; Arnold WD; Sahenk Z; Hartzell HC; Rodino-Klapac LR
    Hum Mol Genet; 2016 May; 25(10):1900-1911. PubMed ID: 26911675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Mutation in Anoctamin 5 Gene Causing Limb-Girdle Muscular Dystrophy 2L.
    Peddareddygari LR; Oberoi K; Baisre-De Leon A; Grewal RP
    J Clin Neuromuscul Dis; 2018 Jun; 19(4):228-231. PubMed ID: 29794579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early-onset limb-girdle muscular dystrophy-2L in a female athlete.
    Blackburn PR; Selcen D; Jackson JL; Guthrie KJ; Cousin MA; Boczek NJ; Clift KE; Klee EW; Dimberg EL; Atwal PS
    Muscle Nerve; 2017 May; 55(5):E19-E21. PubMed ID: 27862037
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic disruption of Ano5 in mice does not recapitulate human ANO5-deficient muscular dystrophy.
    Xu J; El Refaey M; Xu L; Zhao L; Gao Y; Floyd K; Karaze T; Janssen PM; Han R
    Skelet Muscle; 2015; 5():43. PubMed ID: 26693275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing clinical data and muscle imaging of DYSF and ANO5 related muscular dystrophies.
    Ten Dam L; van der Kooi AJ; Rövekamp F; Linssen WH; de Visser M
    Neuromuscul Disord; 2014 Dec; 24(12):1097-102. PubMed ID: 25176504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.